Yasuo Suzuki

11.1k citations

275 papers · 5.8k indexed · h-index 42

Genetics top 0.5%
- Inflammatory Bowel Disease 110
Epidemiology top 1%
- Microscopic Colitis 76
- Autoimmune and Inflammatory Disorders 18
Gastroenterology top 1%
Rheumatology top 1%
- Rheumatoid Arthritis Research and Therapies 14
- Systemic Lupus Erythematosus Research 13
Immunology top 2%
- Immunodeficiency and Autoimmune Disorders 18
Neurology
- Vestibular and auditory disorders 14
Cognitive Neuroscience
- Visual perception and processing mechanisms 13

Co-authors: Toshifumi Hibi∥Mamoru Watanabe Kenshiro Ohara Koichi Ohara Naoki Yoshimura Toshiyuki Matsui Miho Nagai Satoshi Motoya
Cited by: Genetics Epidemiology Gastroenterology
Journals: Journal of Neuroscience (1 paper)SHILAP Revista de lepidopterología (4 papers)Gastroenterology (12 papers)
Partner nations: Japan United States Switzerland

In The Last Decade

Yasuo Suzuki

265 papers receiving 5.6k citations

Peers

Countries citing papers authored by Yasuo Suzuki

Since Specialization

Citations

This map shows the geographic impact of Yasuo Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuo Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuo Suzuki more than expected).

Fields of papers citing papers by Yasuo Suzuki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuo Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuo Suzuki. The network helps show where Yasuo Suzuki may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yasuo Suzuki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yasuo Suzuki Line = papers co-authored together Yasuo Suzuki links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Congenital Pulmonary Lymphangiectasia Masked by Postoperative Pulmonary Venous Obstruction in an Infant with Total Anomalous Pulmonary Venous Connection International Heart Journal ·Yoshiko Nawata,Daisuke Toyomura,Seigo Okada,Yasuo Suzuki,Narumi Honda-Nakada,Yuji Ohnishi,Yuichiro Sugitani,Naoki Kawaguchi,Rui Tokitaka‐Okada,N Masaki,Eiji Ikeda,Shunji Hasegawa	2024	2
2	Evaluation of quadriceps muscle cross-sectional area using an ultrasonic diagnostic equipment with a wide field of view PLoS ONE ·Yasumoto Matsui,Marie Takemura,Yasuo Suzuki,Tsuyoshi Watanabe,Keisuke Maeda,Shosuke Satake,Hidenori Arai	2024	2
3	Mutation Analysis of Autosomal-Dominant Polycystic Kidney Disease Patients Genes ·Yasuo Suzuki,Kan Katayama,Ryosuke Saiki,Yosuke Hirabayashi,Tomohiro Murata,Eiji Ishikawa,Masaaki Ito,Kaoru Dohi	2023	4
4	Advanced endoscopy for the management of inflammatory digestive diseases: Review of the Japan Gastroenterological Endoscopy Society core session Digestive Endoscopy ·Minoru Matsuura,Takayuki Matsumoto,Yuji Naito,Yusuke Saitoh,Takanori Kanai∥,Yasuo Suzuki,Shinji Tanaka,Haruhiko Ogata,Tadakazu Hisamatsu	2022	2
5	Differences in the mass and quality of the quadriceps with age and sex and their relationships with knee extension strength Journal of Cachexia Sarcopenia and Muscle ·Takafumi Mizuno,Yasumoto Matsui,Makiko Tomida,Yasuo Suzuki,Yukiko Nishita,Chikako Tange,Hiroshi Shimokata,Shiro Imagama,Rei Otsuka,Hidenori Arai	2021	38
6	Management of Primary Nonresponders and Partial Responders to Tumor Necrosis Factor-α Inhibitor Induction Therapy among Patients with Crohn’s Disease Inflammatory Intestinal Diseases ·Hideki Iijima,Taku Kobayashi,Mitsuo Nagasaka,Shinichiro Shinzaki,Kazuya Kitamura,Yasuo Suzuki,Mamoru Watanabe,Toshifumi Hibi∥,(unknown)	2020	5
7	Ulcerative colitis-related severe enteritis: an infrequent but serious complication after colectomy Journal of Gastroenterology ·Atsushi Kohyama,Kazuhiro Watanabe,Akira Sugita,Kitaro Futami,Hiroki Ikeuchi,Ken-ichi Takahashi,Yasuo Suzuki,Kouhei Fukushima	2020	13
8	Long-term safety and effectiveness of adalimumab in 462 patients with intestinal Behçet’s disease: results from a large real-world observational study Intestinal Research ·Yasuo Suzuki,Takashi Hagiwara,Mariko Kobayashi,Kazuo Morita,T Shimamoto,Toshifumi Hibi∥	2020	21
9	High-resolution melt analysis enables simple genotyping of complicated polymorphisms of codon 18 rendering the NUDT15 diplotype Journal of Gastroenterology ·(unknown),Yoichi Kakuta,Yasuhiro Izumiyama,Daisuke Okamoto,Takeru Nakano,Ryo Ichikawa,Takeo Naito,Rintaro Moroi,Masatake Kuroha,Yoshitake Kanazawa,Tomoya Kimura,Hisashi Shiga,Hisaaki Kudo,Naoko Minegishi,Yosuke Kawai,Katsushi Tokunaga,Masao Nagasaki,Yoshitaka Kinouchi,Yasuo Suzuki,Atsushi Masasmune	2019	7
10	Infliximab versus intravenous immunoglobulin for refractory Kawasaki disease: a phase 3, randomized, open-label, active-controlled, parallel-group, multicenter trial Scientific Reports ·Masaaki Mori,Takuma Hara,Masako Kikuchi,Hiroyuki Shimizu,Tomoyuki Miyamoto,Satoru Iwashima,Tatsuya Oonishi,Kunio Hashimoto,Norimoto Kobayashi,Kenji Waki,Yasuo Suzuki,Yoshikazu Otsubo,Hiroshi Yamada,Chikao Ishikawa,Taichi Kato,Shigeto Fuse	2018	50
11	Postoperative therapy with infliximab for Crohn’s disease: a 2-year prospective randomized multicenter study in Japan Surgery Today ·Kouhei Fukushima,Akira Sugita,Kitaro Futami,Ken-ichi Takahashi,Satoshi Motoya,Hideaki Kimura,Shusaku Yoshikawa,Yoshitaka Kinouchi,Hideki Iijima,Katsuya Endo,Toshihumi Hibi,Mamoru Watanabe,Iwao Sasaki,Yasuo Suzuki	2018	22
12	Granulomatous interstitial nephritis due to chronic lymphocytic leukemia: a case report BMC Nephrology ·Yasuo Suzuki,Kan Katayama,Eiji Ishikawa,Shoko Mizoguchi,Keiko Oda,Yosuke Hirabayashi,Ayumi Haruki,Takayasu Ito,Mika Fujimoto,Tomohiro Murata,Masaaki Ito	2017	6
13	A Case of Dermatomyositis and Anti-EJ Autoantibody with Chronic Intestinal Pseudoobstruction Successfully Treated with Octreotide SHILAP Revista de lepidopterología ·Chiho Yamada,Shinji Sato,Noriko Sasaki,Takayoshi Kurabayashi,Sho Sasaki,Yasushi Koyama,Naofumi Chinen,Takayuki Wakabayashi,Yasuo Suzuki	2016	5
14	Circulating Interleukin 6 and Albumin, and Infliximab Levels Are Good Predictors of Recovering Efficacy After Dose Escalation Infliximab Therapy in Patients with Loss of Response to Treatment for Crohnʼs Disease Inflammatory Bowel Diseases ·Yasuo Suzuki,Toshiyuki Matsui,Hiroaki Ito,Toshifumi Ashida,Shirô Nakamura,Satoshi Motoya,Takayuki Matsumoto,Noriko Sato,Kunihiko Ozaki,Mamoru Watanabe,Toshifumi Hibi∥	2015	38
15	C-reactive protein is an indicator of serum infliximab level in predicting loss of response in patients with Crohn’s disease Journal of Gastroenterology ·Toshifumi Hibi∥,Atsushi Sakuraba,Mamoru Watanabe,Satoshi Motoya,Hiroaki Ito,Noriko Sato,Toru Yoshinari,Kenta Motegi,Yoshitaka Kinouchi,Masakazu Takazoe,Yasuo Suzuki,Takayuki Matsumoto,Kazuhiko Kawakami,Ichiro Hirata,Shinji Tanaka,Toshifumi Ashida,Toshiyuki Matsui	2013	50
16	Genome-wide linkage and association mapping identify susceptibility alleles in ABCC4 for Kawasaki disease Journal of Medical Genetics ·Chiea Chuen Khor,Sonia Dávila,Chisato Shimizu,S. Sheng,Tsukasa Matsubara,Yasuo Suzuki,Jane W. Newburger,Annette Baker,David Burgner,Willemijn B. Breunis,Taco Kuijpers,Victoria Wright,Michael Levin,Martin L. Hibberd,Jane C. Burns,(unknown)	2011	42
17	Clinical trial: effects of an oral preparation of mesalazine at 4 g/day on moderately active ulcerative colitis. A phase III parallel-dosing study Journal of Gastroenterology ·Nobuo Hiwatashi,Yasuo Suzuki,Keiichi Mitsuyama,Akihiro Munakata,Toshifumi Hibi∥	2010	25
18	Leukocytapheresis in Ulcerative Colitis: Results of a Multicenter Double-Blind Prospective Case-Control Study with Sham Apheresis as Placebo Treatment The American Journal of Gastroenterology ·Koji Sawada,Kazuo Kusugami,Yasuo Suzuki,Tadao Bamba,Akihiro Munakata,Toshifumi Hibi∥,Takashi Shimoyama	2005	96
19	Anticipation and Imprinting in Schizophrenia Biological Psychiatry ·Koichi Ohara,(unknown),Huo-Din Xu,Norio Mori,Yasuo Suzuki,Dongsheng Xu,Kenshiro Ohara,Zucheng Wang	1997	35
20	Solution properties of sodium alginate from brown seaweeds living along the coast of Japan. I. "Arame" Eisenia bicylis. NIPPON SUISAN GAKKAISHI ·Takahide Saito,Naomichi Iso,Haruo Mizuno,Susumu Fujii,Yasuo Suzuki	1977	2

About Yasuo Suzuki

Yasuo Suzuki is a scholar working on Genetics, Epidemiology and Rheumatology, having authored 275 papers that have together received 5.8k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (110 papers), Microscopic Colitis (76 papers), Immunodeficiency and Autoimmune Disorders (18 papers), Autoimmune and Inflammatory Disorders (18 papers), Vestibular and auditory disorders (14 papers), Rheumatoid Arthritis Research and Therapies (14 papers), Systemic Lupus Erythematosus Research (13 papers) and Visual perception and processing mechanisms (13 papers). The work is most often cited by research in Genetics (2.8k citations), Epidemiology (2.1k citations) and Gastroenterology (325 citations). Yasuo Suzuki has collaborated with scholars based in Japan, United States and Switzerland. Frequent co-authors include Toshifumi Hibi∥, Mamoru Watanabe, Kenshiro Ohara, Koichi Ohara, Naoki Yoshimura, Toshiyuki Matsui, Miho Nagai, Satoshi Motoya, Takayuki Matsumoto and K. Hepp. Their work appears in journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact